Retrospective analyses of clinical tumor samples identify TGFβ1 as the most prevalent TGFβ isoform in most solid cancers Preclinical results demonstrate highly selective inhibition of TGFβ1 activation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback